Sensorcaine with Epinephrine

Phase 3Small molecule

AAmin Javer

Sensorcaine with Epinephrine is one of 9 small molecule programs targeting Bupivacaine. It is currently in Phase 3.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

BupivacaineRecruiting

BupivacainePhase 3

Recruiting

Competition

Competitive Landscape

14 competitors in Bupivacaine

#DrugCompanyPhaseTrials

Marcaine

IInnocoll

Approved

29 2

EXPAREL

Pacira Pharmaceuticals, Inc

Phase 3

3 3

Bupivacain

IIstanbul University

Phase 2

3 4

Ketalar

AAultman Health Foundation

Phase 1

3 5

AMPHADASE

AAntares Pharma Inc.

Phase 1

1 6

Sensorcaine with Epinephrine

AAmin Javer

Phase 3

1 7

Bupivacaine Liposomes(bl)

HHuazhong University of Science and Technology

Phase 3

1 8

Ophthaine

VVitae Pharmaceuticals Inc., an Allergan affiliate

Preclinical

1 9

Warm Bupivacaine

MMansoura University

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Bupivacaine1 trial

Bupivacaine and Epinephrine Injection Study

Recruiting·AAmin Javer·Phase 2/3·NCT06456255·80 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Sensorcaine with Epinephrine. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Sensorcaine with Epinephrine compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Sensorcaine with Epinephrine. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Amin Javer company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: AAmin Javer

Sensorcaine with Epinephrine

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Bupivacaine1 trial

References

Drug Info

Quick Facts

Related News